Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27979
Full metadata record
DC FieldValueLanguage
dc.contributor.authorXing, Daniel T-
dc.contributor.authorHettige, Supan-
dc.contributor.authorChee, Lessandra Yan Shan-
dc.contributor.authorNair, Rohan-
dc.contributor.authorHegde, Rajendra-
dc.date2021-10-
dc.date.accessioned2021-11-16T02:50:48Z-
dc.date.available2021-11-16T02:50:48Z-
dc.date.issued2021-10-05-
dc.identifier.citationCureus 2021; 13(10): e18514en
dc.identifier.issn2168-8184
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27979-
dc.description.abstractA 73-year-old man presented to his primary physician with an ulcerative growth on his scalp vertex. Biopsy of the lesion confirmed the growth to be a moderately differentiated squamous cell carcinoma, but the patient declined medical intervention. The lesion increased in size over six months, measuring 12 cm in diameter and 3 cm thickness with erosion of the skull of the vertex. CT and MRI scans showed a large fungating mass with erosion of the skull of vertex without intra-cranial extension, meningeal enhancement, or distant metastatic disease. The patient declined surgical intervention. The patient received radiotherapy using volumetric-modulated arc therapy (VMAT) to a total dose of 60 Gy over six weeks. No evidence of clinical invasive disease apart from a 15 cm * 12 cm skin defect detected three months after completion of radiotherapy. At three years of follow-up, the patient is clinically disease-free. This case report provides evidence that high-dose radiotherapy is a potential effective definitive treatment for locally advanced (T4) squamous cell carcinoma for patients who are unwilling to undergo surgery.en
dc.language.isoeng
dc.subjectcutaneous squamous cell carcinomaen
dc.subjectexternal beam radiationen
dc.subjecthead and neck canceren
dc.subjectradiotherapyen
dc.subjectvolumetric-modulated arc therapyen
dc.titleCurative Radiotherapy for Locally Advanced Scalp Squamous Cell Carcinoma.en
dc.typeJournal Articleen
dc.identifier.journaltitleCureusen
dc.identifier.affiliationRadiation Oncology, William Buckland Radiotherapy Centre, The Alfred Health, Melbourne, AUSen
dc.identifier.affiliationRadiation Oncologyen
dc.identifier.affiliationGippsland Radiation Oncology, Latrobe Regional Hospital, Traralgon, AUSen
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen
dc.identifier.pubmeduri34754673en
dc.identifier.doi10.7759/cureus.18514en
dc.type.contentTexten
dc.identifier.pubmedid34754673
local.name.researcherXing, Daniel T
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Nov 29, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.